-
Something wrong with this record ?
Dynamic oxidoreductive potential of astringent retraction agents
Nowakowska D, Saczko J, Kulbacka J, Choromanska A.
Language English Country Czech Republic
NLK
Free Medical Journals
from 2000
Freely Accessible Science Journals
from 2000
ProQuest Central
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2000
- MeSH
- Astringents toxicity MeSH
- Coloring Agents diagnostic use MeSH
- Chlorides toxicity MeSH
- Fibroblasts drug effects MeSH
- Gingiva cytology drug effects MeSH
- Alum Compounds toxicity MeSH
- Cells, Cultured MeSH
- Humans MeSH
- Oxidation-Reduction drug effects MeSH
- Aluminum Compounds toxicity MeSH
- Tetrazolium Salts diagnostic use MeSH
- Thiazoles diagnostic use MeSH
- Cell Survival drug effects MeSH
- Ferric Compounds toxicity MeSH
- Check Tag
- Humans MeSH
The aim of this study was to evaluate the dynamics of the cytotoxicity of gingival margin retraction astringents based on aluminium chloride, aluminium sulphate, and ferric sulphate (solutions and gels) in human fibroblasts isolated from gingiva. The cytocompatibility of ten astringent-based chemical retraction agents: Gingiva Liquid, Alustin, Racestypine, Orbat sensitive, Astringedent®, Alustat, Hemostat, Racécord, Gel cord and ViscoStat®, in dilutions of 1 : 10 and 1 : 20, with human gingival fibroblasts was investigated. The MTT assay was performed to determine oxidoreductive mitochondrial function after 3, 5, 10 min and 24 h of incubation. Cell viability was determined according to the chemical group, concentration, exposure time, and the clinical form of the gingival retraction agents. Ferric sulphate- based agents were the most cytotoxic, followed by aluminium chloride and aluminium sulphate. The form of the astrigents influenced cell viability. The evaluated astringents may have cytotoxic potential for gingival margin tissues under clinical conditions.
Lit.: 35
- 000
- 00000naa 2200000 a 4500
- 001
- bmc11006059
- 003
- CZ-PrNML
- 005
- 20111210203058.0
- 008
- 110331s2010 xr e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Nowakowska, D.
- 245 10
- $a Dynamic oxidoreductive potential of astringent retraction agents / $c Nowakowska D, Saczko J, Kulbacka J, Choromanska A.
- 314 __
- $a Department of Dental Materials, Wroclaw Medical University, Wroclaw
- 504 __
- $a Lit.: 35
- 520 9_
- $a The aim of this study was to evaluate the dynamics of the cytotoxicity of gingival margin retraction astringents based on aluminium chloride, aluminium sulphate, and ferric sulphate (solutions and gels) in human fibroblasts isolated from gingiva. The cytocompatibility of ten astringent-based chemical retraction agents: Gingiva Liquid, Alustin, Racestypine, Orbat sensitive, Astringedent®, Alustat, Hemostat, Racécord, Gel cord and ViscoStat®, in dilutions of 1 : 10 and 1 : 20, with human gingival fibroblasts was investigated. The MTT assay was performed to determine oxidoreductive mitochondrial function after 3, 5, 10 min and 24 h of incubation. Cell viability was determined according to the chemical group, concentration, exposure time, and the clinical form of the gingival retraction agents. Ferric sulphate- based agents were the most cytotoxic, followed by aluminium chloride and aluminium sulphate. The form of the astrigents influenced cell viability. The evaluated astringents may have cytotoxic potential for gingival margin tissues under clinical conditions.
- 650 _2
- $a kamencové sloučeniny $x toxicita $7 D000534
- 650 _2
- $a sloučeniny hliníku $x toxicita $7 D017607
- 650 _2
- $a adstringencia $x toxicita $7 D001252
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a chloridy $x toxicita $7 D002712
- 650 _2
- $a barvicí látky $x diagnostické užití $7 D004396
- 650 _2
- $a železité sloučeniny $x toxicita $7 D005290
- 650 _2
- $a fibroblasty $x účinky léků $7 D005347
- 650 _2
- $a gingiva $x cytologie $x účinky léků $7 D005881
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a oxidace-redukce $x účinky léků $7 D010084
- 650 _2
- $a tetrazoliové soli $x diagnostické užití $7 D013778
- 650 _2
- $a thiazoly $x diagnostické užití $7 D013844
- 700 1_
- $a Saczko, J.
- 700 1_
- $a Kulbacka, J.
- 700 1_
- $a Choromanska, A.
- 773 0_
- $w MED00011004 $t Folia biologica $g Roč. 56, č. 6 (2010), s. 263-268 $x 0015-5500
- 856 41
- $u https://fb.cuni.cz/Data/files/folia_biologica/volume_56_2010_6/fb2010A0036.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 970 $c 89 $y 2
- 990 __
- $a 20110330145758 $b ABA008
- 991 __
- $a 20110725150416 $b ABA008
- 999 __
- $a ok $b bmc $g 833584 $s 698148
- BAS __
- $a 3
- BMC __
- $a 2010 $b 56 $c 6 $d 263-268 $m Folia biologica (Praha) $x MED00011004
- LZP __
- $a 2011-05/mkme